Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3738582017 | Betamethasone only product in ocular dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3738583010 | Product containing only betamethasone in ocular dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone only product in ocular dose form | a pour principe actif (attribut) | Betamethasone | true | Inferred relationship | Some | 1 | |
| Betamethasone only product in ocular dose form | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Betamethasone only product in ocular dose form | est un(e) (attribut) | Betamethasone only product | true | Inferred relationship | Some | ||
| Betamethasone only product in ocular dose form | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage oculaire (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Betamethasone only product in ocular dose form | est un(e) (attribut) | Product containing betamethasone in ocular dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone sodium phosphate 1 mg/mL ear or eye or nose drops | est un(e) (attribut) | True | Betamethasone only product in ocular dose form | Inferred relationship | Some | |
| Betamethasone sodium phosphate 1 mg/g eye ointment | est un(e) (attribut) | True | Betamethasone only product in ocular dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR